Enteric pathogens and gut function: Role of cytokines and STATs

Gut Microbes

Volumn 1, Issue 5, 2010, Pages

  Shea Donohue, Terez ^a   Fasano, Alessio ^a   Smith, Allen ^b   Zhao, Aiping ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

A E pathogens; Cytokine; Enteric nematodes; Epithelial cell; Mucosal permeability; Smooth muscle; STAT4; STAT6

Indexed keywords

CD4 ANTIGEN; CYTOKINE; JANUS KINASE; STAT PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CELL MATURATION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENE TARGETING; HEMATOPOIETIC CELL; HUMAN; INTESTINE FUNCTION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UPREGULATION;

NEMATODA;

EID: 77957662987     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.1.5.13329     Document Type: Review

References (91)

1. Brierley MM, Fish EN. Stats: multifaceted regulators of transcription. J Interferon Cytokine Res 2005; 25:733-44.
2. Reich NC, Liu L. Tracking STAT nuclear traffic. Nat Rev Immunol 2006; 6:602-12.
3. Darnell JE Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415-21.
4. Darnell JE Jr. STATs and gene regulation. Science 1997; 277:1630-5.
5. Pfitzner E, Kliem S, Baus D, Litterst CM. The role of STATs in inflammation and inflammatory diseases. Curr Pharm Des 2004; 10:2839-50.
6. Sehgal PB. Paradigm shifts in the cell biology of STAT signaling. Semin Cell Dev Biol 2008; 19:329-40.
7. Hoey T, Zhang S, Schmidt N, Yu Q, Ramchandani S, Xu X, et al. Distinct requirements for the naturally occurring splice forms Stat4a and Stat4b in IL-12 responses. EMBO J 2003; 22:4237-48.
8. Martinez A, Varade J, Marquez A, Cenit MC, Espino L, Perdigones N, et al. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum 2008; 58:2598-602.
9. Fung EYMG, Smyth DJ, Howson JMM, Cooper JD, Walker NM, Stevens H, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23//TNFAIP3 as a susceptibility locus. Genes Immun 2008; 10:188-91.
10. Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, McDuffie M, et al. Autoimmune diabetes is blocked in Stat4-deficient mice. J Autoimmun 2004; 22:191-200.
11. Cui G, Qin X, Zhang Y, Gong Z, Ge B, Zang YQ. Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice. J Biol Chem 2009; 284:28420-9.
12. Pang YH, Zheng CQ, Yang XZ, Zhang WJ. Increased expression and activation of IL-12-induced Stat4 signaling in the mucosa of ulcerative colitis patients. Cell Immunol 2007; 248:115-20.
13. Beghe B, Hall IP, Parker SG, Moffatt MF, Wardlaw A, Connolly MJ, et al. Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy 2010; 65:474-81.
14. Yeh HY, Cheng SW, Lin YC, Yeh CY, Lin SF, Soo VW. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency. BMC Medical Genomics 2009; 2:70.
15. Baus D, Nonnenmacher F, Jankowski S, Doring C, Brautigam C, Frank M, et al. STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line. Leukemia 2009; 23:1885-1893.
16. Sperati CJ, Parekh RS, Berthier-Schaad Y, Jaar BG, Plantinga L, Fink N, et al. Association of single-nucleotide polymorphisms in JAK3, STAT4, and STAT6 with new cardiovascular events in incident dialysis patients. Am J Kidney Dis 2009; 53:845-55.
17. Zhong Z, Wen Z, Darnell JE Jr. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci USA 1994; 91:4806-10.
18. Yamamoto K, Quelle FW, Thierfelder WE, Kreider BL, Gilbert DJ, Jenkins NA, et al. Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol 1994; 14:4342-9.
19. Frucht DM, Aringer M, Galon J, Danning C, Brown M, Fan S, et al. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J Immunol 2000; 164:4659-4664.
20. Furuta S, Kagami Si, Tamachi T, Ikeda K, Fujiwara M, Suto A, et al. Overlapping and distinct roles of STAT4 and T-bet in the regulation of T cell differentiation and allergic airway inflammation. J Immunol 2008; 180:6656-62.
21. Mathur AN, Chang HC, Zisoulis DG, Kapur R, Belladonna ML, Kansas GS, et al. T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 2006; 108:1595-1601.
22. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT, et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007; 178:4901-7.
23. Lin JT, Martin SL, Xia L, Gorham JD. TGF-b1 uses distinct mechanisms to inhibit IFN-IIexpression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet. J Immunol 2005; 174:5950-8.
24. Gorelik L, Fields PE, Flavell RA. Cutting edge: TGF-b inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 2000; 165:4773-7.
25. Junttila IS, Mizukami K, Dickensheets H, Meier-Schellersheim M, Yamane H, Donnelly RP, et al. Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ra, IL-13Ra1, and 11c regulates relative cytokine sensitivity. J Exp Med 2008.
26. Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol 1995; 15:3336-43.
27. Urban JF, Jr., Schopf L, Morris SC, Orekhova T, Madden KB, Betts CJ, et al. Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell-and T cell-dependent mechanism. J Immunol 2000; 164:2046-2052.
28. Morimoto M, Morimoto M, Zhao A, Madden KB, Dawson H, Finkelman FD, et al. Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. J Immunol 2006; 176:491-495.
29. Morimoto M, Zhao A, Sun R, Stiltz J, Madden KB, Mentink-Kane M, et al. IL-13 receptor {alpha}2 regulates the immune and functional response to nippostrongylus brasiliensis infection. J Immunol 2009; 183:1934-9.
30. Song G, Chung CS, Rhee R, Cioffi W, Ayala A. Loss of signal transducer and activator of transduction 4 or 6 signaling contributes to immune cell morbidity and mortality in sepsis. Intensive Care Medicine 2005; 31:1564-1569.
31. Salathé M, Kouyos R, Bonhoeffer S. On the causes of selection for recombination underlying the red queen hypothesis. Am Nat 2009; 174:S31-S42.
32. Frankel G, Phillips AD. Attaching effacing escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol 2008; 10:549-556.
33. Binet R, Maurelli AT. Frequency of spontaneous mutations that confer antibiotic resistance in chlamydia spp1. Antimicrob Agents Chemother 2005; 49:2865-73.
34. Day WA, Jr., Fernandez RE, Maurelli AT. Pathoadaptive mutations that enhance virulence: genetic organization of the cadA regions of Shigella spp10. Infect Immun 2001; 69:7471-80.
35. Maurelli AT, Fernandez RE, Bloch CA, Rode CK, Fasano A. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli 20. Proc Natl Acad Sci USA 1998; 95:3943-3948.
36. Fasano A. Toxins and the gut: role in human disease. Gut 2002; 50:iii9-14.
37. Lapointe TK, O'Connor PM, Buret AG. The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrhea. Lab Invest 2009; 89:964-970.
38. Viswanathan VK, Hodges K, Hecht G. Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat Rev Micro 2009; 7:110-119.
39. Viswanathan VK, Weflen A, Koutsouris A, Roxas JL, Hecht G. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis. Am J Physiol Gastrointest Liver Physiol 2008; 294:G1165-G1170.
40. Torchinsky MB, Garaude J, Martin AP, Blander JM. Innate immune recognition of infected apoptotic cells directs TH17 cell differentiation. Nature 2009; 458:78-82.
41. Bellmeyer A, Cotton C, Kanteti R, Koutsouris A, Viswanathan VK, Hecht G. Enterohemorrhagic escherichia coli suppresses inflammatory response to cytokines and its own toxin. Am J Physiol Gastrointest Liver Physiol 2009; 297:G576-G581.
42. Levine MM. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J Infect Dis 1987; 155:377-389.
43. Symonds EL, Riedel CU, O'Mahony D, Lapthorne S, O'Mahony L, Shanahan F. Involvement of T helper type 17 and regulatory T cell activity in Citrobacter rodentium invasion and inflammatory damage. Clin Exp Immunol 2009; 157:148-154.
44. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14:275-281.
45. Spehlmann ME, Dann SM, Hruz P, Hanson E, McCole DF, Eckmann L. CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. J Immunol 2009; 183:3332-43.
46. Borenshtein D, Fry R, Groff E, Nambiar P, Carey V, Fox J, et al. Diarrhea as a cause of mortality in a mouse model of infectious colitis. Genome Biol 2008; 9:R122.
47. Gill RK, Borthakur A, Hodges K, Turner JR, Clayburgh DR, Saksena S, et al. Mechanism underlying inhibition of intestinal apical CE/OH exchange following infection with enteropathogenic E. coli. J Clin Invest 2007; 117:428-37.
48. O'Hara JR, Skinn AC, MacNaughton WK, Sherman PM, Sharkey KA. Consequences of citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol 2006; 8:646-60.
49. Matkowskyj KA, Danilkovich A, Marrero J, Savkovic SD, Hecht G, Benya RV. Galanin-1 receptor upregulation mediates the excess colonic fluid production caused by infection with enteric pathogens. Nat Med 2000; 6:1048-1051.
50. Finkelman FD, Shea-Donohue T, Morris SC, Gildea L, Strait R, Madden KB, et al. Interleukin-4-and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev 2004; 201:139-55.
51. Madden KB, Whitman L, Sullivan C, Gause WC, Urban JF Jr., Katona IM, et al. Role of STAT6 and mast cells in IL-4-and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol 2002; 169:4417-4422.
52. Madden KB, Yeung KA, Zhao A, Gause WC, Finkelman FD, Katona IM, et al. Enteric nematodes induce stereotypic STAT6-dependent alterations in intestinal epithelial cell function. J Immunol 2004; 172:5616-21.
53. Shea-Donohue T, Sullivan C, Finkelman FD, Madden KB, Morris SC, Goldhill J, et al. The role of IL-4 in heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function. J Immunol 2001; 167:2234-9.
54. Jacob C, Yang PC, Darmoul D, Amadesi S, Saito T, Cottrell GS, et al. Mast cell tryptase controls paracellular permeability of the intestine: role of proteaseactivated receptor 2 and {beta}-arrestins. J Biol Chem 2005; 280:31936-48.
55. Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells 1. Lab Invest 2005; 85:1139-62.
56. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002; 115:4969-76.
57. Shea-Donohue T, Notari L, Stiltz J, Sun R, Madden KB, Urban Jr JF, et al. Role of enteric nerves in immune-mediated changes in protease-activated receptor 2 effects on gut function. Neurogastroenterol Motil. 2010; [Epub, July 11]
58. Motomura Y, Ghia JE, Wang H, Akiho H, El-Sharkawy RT, Collins M, et al. Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments. Gut 2008; 57:475-81.
59. Cliffe LJ, Humphreys NE, Lane TE, Potten CS, Booth C, Grencis RK. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion 1. Science 2005; 308:1463-5.
60. Sethi AK, Sarna SK. Colonic motor activity in acute colitis in conscious dogs. Gastroenterology 1991; 100:954-63.
61. Hosseini JM, Goldhill JM, Bossone C, Pineiro-Carrero V, Shea-Donohue T. Progressive alterations in circular smooth muscle contractility in TNBS-induced colitis in rats 18. Neurogastroenterol Motil 1999; 11:347-56.
62. Snape WJ Jr., Williams R, Hyman PE. Defect in colonic smooth muscle contraction in patients with ulcerative colitis. Am J Physiol 1991; 261:G987-G991.
63. Reevesdarby VG, Turner JA, Prasad R, Chopra AK, Chary P, Clench MH, et al. Effect of cloned salmonellatyphimurium enterotoxin on rabbit intestinal motility. Fems Microbiology Letters 1995; 134:239-44.
64. Accarino AM, Azpiroz F, Malagelada IR. Distinctive motor-responses to human acute salmonellosis in the jejunum and ileum. J Gastrointest Motil 1993; 5:23-31.
65. Hu W, Mahavadi S, Li F, Murthy KS. Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta. Am J Physiol Cell Physiol 2007; 293:C1991-C2000.
66. Hu W, Li F, Mahavadi S, Murthy KS. Interleukin-1beta up-regulates RGS4 through the canonical IKK2/ IkappaBalpha/NF-kappaB pathway in rabbit colonic smooth muscle. Biochem J 2008; 412:35-43.
67. Pazdrak K, Shi XZ, Sarna SK. TNFalpha suppresses human colonic circular smooth muscle cell contractility by SP1-and NF-kappaB-mediated induction of ICAM-1. Gastroenterology 2004; 127:1096-1109.
68. Zhao A, Morimoto M, Dawson H, Elfrey JE, Madden KB, Gause WC, et al. Immune regulation of proteaseactivated receptor-1 expression in murine small intestine during Nippostrongylus brasiliensis infection. J Immunol 2005; 175:2563-9.
69. Zhao A, McDermott J, Urban JF, Jr., Gause W, Madden KB, Yeung KA, et al. Dependence of IL-4, IL-13, and nematode-induced alterations in murine small intestinal smooth muscle contractility on Stat6 and enteric nerves. J Immunol 2003; 171:948-54.
70. Akiho H, Blennerhassett P, Deng Y, Collins SM. Role of IL-4, IL-13, and STAT6 in inflammationinduced hypercontractility of murine smooth muscle cells 3. Am J Physiol Gastrointest Liver Physiol 2002; 282:G226-G232.
71. Khan WI, Richard M, Akiho H, Blennerhasset PA, Humphreys NE, Grencis RK, et al. Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections 2. Infect Immun 2003; 71:2430-8.
72. Madden KB, Urban JF, Jr., Ziltener HJ, Schrader JW, Finkelman FD, Katona IM. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis 25. J Immunol 1991; 147:1387-91.
73. Goldhill JM, Finkelman FD, Morris SC, Shea-Donohue T. Neural control of mouse small intestinal longitudinal muscle: interactions with inflammatory mediators. J Pharmacol Exp Ther 1995; 274:72-7.
74. Sjogren RW, Colleton C, Shea-Donohue T. Intestinal myoelectric response in two different models of acute enteric inflammation 3. Am J Physiol 1994; 267:G329-G337.
75. Zhao A, Urban Jr JF, Anthony RM, Sun R, Stiltz J, van Rooijen N, et al. Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 2008; 135:217-25.
76. Akiho H, Khan WI, Al-Kaabi A, Blennerhassett P, Deng Y, Collins SM. Cytokine modulation of muscarinic receptors in the murine intestine. Am J Physiol Gastrointest Liver Physiol 2007; 293:G250-G255.
77. Zhao A, Urban JF, Jr., Morimoto M, Elfrey JE, Madden KB, Finkelman FD, et al. Contribution of 5-HT2A receptor in nematode infection-induced murine intestinal smooth muscle hypercontractility. Gastroenterology 2006; 131:568-78.
78. Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. IL-17 cytokine family. J Allergy Clin Immunol 2004; 114:1265-73.
79. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21:467-76.
80. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821-52.
81. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001; 15:985-95.
82. Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, Gorman DM, et al. IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 2007; 204:161-70.
83. Owyang AM, Zaph C, Wilson EH, Guild KJ, McClanahan T, Miller HR, et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 2006; 203:843-9.
84. Chang S, Aune TM. Dynamic changes in histonemethylation 'marks' across the locus encoding interferon-[ gamma] during the differentiation of T helper type 2 cells. Nat Immunol 2007; 8:723-31.
85. Aune TM, Collins PL, Chang S. Epigenetics and T helper 1 differentiation. Immunology 2009; 126:299-305.
86. Good SR, Thieu VT, Mathur AN, Yu Q, Stritesky GL, Yeh N, et al. Temporal induction pattern of STAT4 target genes defines potential for Th1 lineage-specific programming. J Immunol 2009; 183:3839-47.
87. Thieu VT, Yu Q, Chang HC, Yeh N, Nguyen ET, Sehra S, et al. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 2008; 29:679-90.
88. Lund RJ, Chen Z, Scheinin J, Lahesmaa R. Early target genes of IL-12 and STAT4 signaling in Th cells. J Immunol 2004; 172:6775-82.
89. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, Duschl A. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 2006; 17:173-88.
90. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002; 365:561-75.
91. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996; 93:6231-5.